Assessement of a Novel Approach to Ultrasound-guided Brachial Plexus Blockade

NCT ID: NCT03653000

Last Updated: 2022-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2023-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assessement of a new approach of an ultrasound guided brachial plexus blockade between the infraclavicular and axillary area.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After an assessement of this new approach of ultrasounded-guided brachial plexus blockade in cadavers, the aim of this human study was to asssess the validity of this method in humans. The probe will be disposed on the shoulder, and the brachial plexus will be seeked below the deltoid, lateral to the major pectoralis muscle and in the vicinity of the brachial artery. At this area, an ultrasounded guided needle was inserted with an in-plane direction towards the brachial artery and local anesthetics was disposed all around the artery, without puncturing the differents nerves. Regional blockade will be evaluated by measuring onset and duation time for sensitive and motor blockade, effectiveness of this blockade, patient's confort during the procedure, ease of the procedure for practitionner, quality of ultrasound image's interpretation before and after injection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nerve Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Descriptive study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing this new block

Descriptive study about the effectiveness and the feasability of this new approach of te ultrasound guided brachial plexus blockade

Group Type EXPERIMENTAL

Ultrasound guided brachial plexus blockade

Intervention Type PROCEDURE

Ultrasound probe disposed on the shoulder, on the deltoid muscle. in plane puncture toward the brachial artery and injection of local anaesthetics around the brachial artery

local anaesthetic injection

Intervention Type DRUG

Local anesthetic injection (ropivacaine) at this new site

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound guided brachial plexus blockade

Ultrasound probe disposed on the shoulder, on the deltoid muscle. in plane puncture toward the brachial artery and injection of local anaesthetics around the brachial artery

Intervention Type PROCEDURE

local anaesthetic injection

Local anesthetic injection (ropivacaine) at this new site

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Arm surgery performed under axillary blockade

Exclusion Criteria

* Local anesthetics allergy
* Coagulation disorder
* History of chronic pain
* Drug or alcohol abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

J P Lecoq

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Guntz Emmanuel

Braine-l'Alleud, Brabant Wallon, Belgium

Site Status RECRUITING

Lecoq Jean-Pierre

Liège, Liege, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Pierre H Lecoq, MD, PhD

Role: CONTACT

42844096 ext. 32

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guntz Emmanuel, MD

Role: primary

023890211 ext. 0032

Lecoq H Jean-Pierre, MD

Role: primary

043667180 ext. 0032

Lecoq H [email protected], MD

Role: backup

043667180 ext. 0032

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Parasagittal Vs Cornerpocket Approaches
NCT06352333 NOT_YET_RECRUITING NA